Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed a non- exclusive distribution agreement for the commercialization of SYGNIS’ proprietary product portfolio in Australia with GeneWorks Pty Ltd. Under the terms of the agreement, SYGNIS has granted GeneWorks the rights to promote, market and […]

Madrid, Spain and Heidelberg, Germany – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that it has signed a distribution agreement with Nanodigmbio Co. Ltd. for the commercialization of SYGNIS’ proprietary product portfolio in China. China is set to become a crucial player in the healthcare and life sciences industry and is expected […]

OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO) today announced the launch of its MX-ICP EGFR Analysis lung cancer panel that covers key actionable mutations while providing precision detection levels down to as low as 0.01%. The panel uses Transgenomic’s Multiplexed ICE COLD-PCR™ (MX-ICP) technology, which generates highly accurate results from small amounts of blood or […]

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it has signed a definitive agreement to acquire Kapa Biosystems, Inc. (Kapa) a privately-held company headquartered in Wilmington, Massachusetts, US. Kapa Biosystems is a provider of genomic tools in the life sciences sector that employs proprietary technologies to optimize enzymes for next-generation sequencing (NGS), as well as […]

DELRAY BEACH, Fla. — PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today it has entered into definitive agreements with an institutional investor (“Investor”) for an aggregate purchase price of $2,400,000. PositiveID will use the proceeds to continue the development and testing of its Firefly Dx PCR (polymerase […]

Hercules, CA —— Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of theddPCR™ Supermix for Residual DNA Quantification. When used with Bio-Rad’s Droplet Digital™ PCR Systems, this supermix provides a highly precise and sensitive method for directly measuring host cell DNA (HCD) that contaminates biopharmaceutical products. To manufacture therapeutic proteins, vaccines, and […]

Goettingen, Germany — Eurogentec (EGT) is a leading provider of innovative products and services to the life science, diagnostic, and pharmaceutical community. MoBiTec is selling the products of AnaSpec, which now is part of EGT, for more than 10 years already. The agreement allows MoBiTec to also offer EGT’s state-of-the-art qPCR kits, oligonucleotides, and further […]

SUNNYVALE, Calif. — Cepheid (Nasdaq: CPHD) today announced the departure of Ilan Daskal who held the position of Executive Vice President, Chief Financial Officer. Mr. Daskal’s departure is not related to financial disclosure, accounting or legal matters. The company also announced the appointment of Dan Madden to the position of Executive Vice President, Chief Financial […]

OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO) today announced that it has established a Clinical-Commercial Advisory Board (CCAB) for oncology applications of its Multiplexed ICE COLD-PCRTM (MX-ICP) technology. The CCAB is headed by Dr. Scott Patterson, a recognized expert in the application of genetic biomarkers to cancer drug development. Also joining as inaugural CCAB members […]

Jena, Germany — Endress+Hauser’s voluntary tender to the shareholders of Analytik Jena AG has been extended to 9 September 2015. The Group, which holds more than 95 percent of the German company, will continue to offer 14 euros a share The voluntary tender from Endress+Hauser was first initiated in July of this year. Following the […]